Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

High-risk Leukemias × Other hematologic neoplasm × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 3104 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2207 Leukemia 2131 Leukemia, Lymphocytic, Chronic, B-Cell 1776 Myelodysplastic Syndromes 1248 Hematologic Neoplasms 1214 Lymphoma 1049 Lymphoma, Non-Hodgkin 953 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 768 Lymphoma, Follicular 674 Multiple Myeloma 652 Lymphoma, Mantle-Cell 646 Lymphoma, Large B-Cell, Diffuse 638 Burkitt Lymphoma 616 Lymphoma, B-Cell, Marginal Zone 566 Hodgkin Disease 552 Recurrence 540 Leukemia, Myelomonocytic, Chronic 475 Neoplasms 452 Lymphoma, Large-Cell, Immunoblastic 401 Myeloproliferative Disorders 394 Leukemia, Myeloid, Chronic-Phase 391 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 357 Congenital Abnormalities 355 Blast Crisis 313 Waldenstrom Macroglobulinemia 312 Leukemia, Myeloid, Accelerated Phase 281 Lymphoma, T-Cell, Cutaneous 275 Primary Myelofibrosis 263 Neoplasms, Plasma Cell 245

Interventions

Interleukin-15 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05304754 2025-04-06

PHINK

Instituto de Investigación Hospital Universitario La Paz

Phase 1/2 Active not recruiting

Other hematologic neoplasm

High-risk Leukemias

Data powered by HemOnc (CC BY 4.0) Colophon ⚡